Firms

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

Lightspeed

• Alpha-9$175M · 2024-10-23
• Alpha-9 Oncology, Inc.$175M · 2024-10-23
• Diagonal Therapeutics$128M · 2024-04-03
• Alpha-9 Oncology, Inc.$175M · 2024

Samsara BioCapital

• Alpha-9$175M · 2024-10-23
• Alpha-9 Oncology, Inc.$175M · 2024-10-23
• Enlaza Therapeutics$100M · 2024-04-30
• Alpha-9 Oncology, Inc.$175M · 2024

Delos Capital

• Alpha-9$175M · 2024-10-23
• Alpha-9 Oncology, Inc.$175M · 2024-10-23
• Alpha-9 Oncology, Inc.$175M · 2024

General Catalyst

• Alpha-9$175M · 2024-10-23
• Alpha-9 Oncology, Inc.$175M · 2024-10-23
• Alpha-9 Oncology, Inc.$175M · 2024

Longitude Capital

• Alpha-9$175M · 2024-10-23
• Alpha-9 Oncology, Inc.$175M · 2024-10-23
• Alpha-9 Oncology, Inc.$175M · 2024

SHOW MORE

Investments

$175M2024-10-23	Alpha-9	General Catalyst, Lightspeed, Samsara BioCapital, Longitude Capital, Delos Capital, Nextech Invest, Frazier Life Sciences
$175M2024-10-23	Alpha-9 Oncology, Inc.	General Catalyst, Lightspeed, Samsara BioCapital, Longitude Capital, Delos Capital, Nextech Invest, Frazier Life Sciences
$100M2024-04-30	Enlaza Therapeutics	J.P. Morgan Private Capital Life Sciences, Pappas Capital, Bregua Corporation, Alexandria Venture Investments, Avalon Ventures, Lightspeed Venture Partners, Samsara BioCapital, Amgen Ventures, Frazier Life Sciences, Regeneron Ventures
$128M2024-04-03	Diagonal Therapeutics	Lightspeed, Atlas Venture, Viking Global Investors, BVF Partners L.P., Frazier Life Sciences, Velocity Capital Fintech Ventures
$175M2024	Alpha-9 Oncology, Inc.	General Catalyst, Lightspeed, Samsara BioCapital, Longitude Capital, Delos Capital, Nextech Invest, Frazier Life Sciences

SHOW MORE